ERBB2 and breast carcinoma: Mazzarella and colleagues analyzed 1250 patients with early-stage HER2-positive breast cancer and found that obesity (BMI ≥ 30) was significantly associated with a worse OS and a higher incidence of distant metastases in the ER-negative subgroup.